On October 26, 2017 Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, reported that it plans to host a conference call and webcast on Monday, November 6, 2017 at 5:00 p.m. ET to discuss its third quarter 2017 financial results and provide a corporate update (Press release, Keryx Biopharmaceuticals, OCT 26, 2017, View Source [SID1234521215]).

To participate in the conference call, please dial 1-888-396-2320 (U.S.), 1-774-264-7560 (international) and refer to conference ID: 2193619. The call will be webcast live with slides and accessible through the Investors section of the company’s website at www.keryx.com for a period of 15 days after the call.

On October 26, 2017 Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company reported that it will host a conference call at 1:30 p.m. PST/4:30 p.m. EST on Thursday, November 9, 2017, following release of its third quarter 2017 financial results (Press release, Puma Biotechnology, OCT 26, 2017, http://investor.pumabiotechnology.com/press-release/puma-biotechnology-host-conference-call-discuss-third-quarter-financial-results [SID1234521216]).

The call may be accessed by dialing 1-877-709-8150 (domestic) or 1-201-689-8354 (international). Please dial in at least ten minutes in advance and inform the operator that you would like to join the “Puma Biotechnology Conference Call.” A live webcast of the conference call and presentation slides may be accessed on the Investors section of the Puma Biotechnology website at View Source A replay of the call will be available approximately one hour after completion of the call and will be archived on the company’s website for 90 days.

On October 26, 2017 Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology Company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, reported that it will host a teleconference and webcast with management to discuss the third quarter 2017 financial results, provide an update on the Company’s business, and discuss expectations for the future (Press release, Spectrum Pharmaceuticals, OCT 26, 2017, View Source [SID1234521203]).

Conference Call

Thursday, November 2, 2017 @ 4:30 p.m. Eastern/1:30 p.m. Pacific

Domestic: (877) 837-3910, Conference ID# 7488227
International: (973) 796-5077, Conference ID# 7488227

For interested individuals unable to join the call, a replay will be available from November 2, 2017 @ 7:30 p.m. ET/4:30 p.m. PT through November 12, 2017 until 11:59 p.m. ET/8:59 p.m. PT.

Domestic Replay Dial-In #: (855) 859-2056, Conference ID# 7488227
International Replay Dial-In #: (404) 537-3406, Conference ID# 7488227

This conference call will also be webcast. Listeners may access the webcast, which will be available on the investor relations page of Spectrum Pharmaceuticals’ website: www.sppirx.com on November 2, 2017 at 4:30 p.m. Eastern/1:30 p.m. Pacific.

MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) will publish its first nine months’ 2017 results on November 7, 2017 at 7:00 am CET (Press release, MorphoSys, OCT 26, 2017, View Source [SID1234521200]).

At 2:00 pm CET (1:00 pm GMT, 8:00 am EST), the Management Board of MorphoSys AG will host a public conference call and webcast to present MorphoSys’s financial results for the first nine month of 2017 and provide further details on the Company’s latest developments.

Dial-in numbers (listen only):

Germany: +49 89 2444 32975

United Kingdom: +44 20 3003 2666

USA: +1 202 204 1514

We request that you please dial in up to 10 minutes before the call to ensure a prompt start and a secure line.

The presentation slides and webcast link will be available at the Company’s website at www.morphosys.com/conference-calls

A slide-synchronized audio replay of the conference will also be available at the corporate website following the live event.